Medicines Law & Policy Expert Wins Prescrire Prize For ‘Major Reference Work’ On Access To Medicines 05/10/2017 by Guest contributor for Intellectual Property Watch Leave a Comment Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) The views expressed in this article are solely those of the authors and are not associated with Intellectual Property Watch. IP-Watch expressly disclaims and refuses any responsibility or liability for the content, style or form of any posts made to this forum, which remain solely the responsibility of their authors. PARIS — La Revue Prescrire, a French journal for healthcare professionals, has chosen “Private Patents and Public Health” — a 2016 book written by Ellen ’t Hoen — as one of four winners of its 2017 Prescrire Prize Book Award. Calling it “a major reference work on access to medicines and the patent system,” Prescrire praised ’t Hoen’s book both for its extensive collection of data and examples as well as its readability. (Medicines Law & Policy contributor, Kaitlin Mara was the editor of the book). Intended as a comprehensive history of the access to medicines movement to-date, Private Patents and Public Health is the culmination of ’t Hoen’s 30 years of experience promoting better access to better medicines at affordable prices. It tracks the evolution and globalisation of strict rules for patenting, the resistance of public health advocates leading to somewhat greater recognition and use of flexibilities in the patent system, and presents thoughts on how current patent regimes may be reformed to meet the health needs of today and incentivise work to meet the health needs of tomorrow. Shortly after the publication of the book, ’t Hoen spearheaded the launch of Medicines Law & Policy [www.medicineslawandpolicy.org), a consortium of experts devoted to providing resources that governments and other stakeholders can use to make their patent system better serve public health. In particular, ML&P’s free-to-use suite of tools provide easy to understand and implement ways to take advantage of several key flexibilities described in Private Patents and Public Health as critical to having increased access to medicines for several deadly illnesses, and in particular for HIV. To access the book: www.accesstomedicines.org To buy the book: http://www.amb-press.nl/Webwinkel-Product-173747881/%E2%80%98t-Hoen-%E2%80%93-Private-Patents-and-Public-Health.html Share this:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Related Guest contributor may be reached at info@ip-watch.ch."Medicines Law & Policy Expert Wins Prescrire Prize For ‘Major Reference Work’ On Access To Medicines" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.